Rare diseases
Investigational molecules
Locations
Ring Road Of Thessaloniki, Ministry Of Pavlos Melas, 564 29 Efkarpia, Greece
General Hospital Of Thessaloniki Papageorgiou in Efkarpia, Greece specialises in clinical trials of conditions such as Hidradenitis, Non-small cell lung cancer, Dermatitis atopic, Arteriosclerosis, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GreeceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GreeceA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GreeceStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GreeceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GreeceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GreeceStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
GreeceStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
GreeceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GreeceStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
GreecePhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
GreecePumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
GreeceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
